Intranasal exosomes for treatment of neuroinflammation? Prospects and limitations.

Intranasal exosomes for treatment of neuroinflammation? Prospects and limitations.

Detalles Bibliográficos
Autores principales:	Lakhal, S, Wood, M
Formato:	Journal article
Lenguaje:	English
Publicado:	2011

Ejemplares similares

Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation
por: Elizabeth M. Rhea, et al.
Publicado: (2020-11-01)

Intranasal Delivery of Gene-Edited Microglial Exosomes Improves Neurological Outcomes after Intracerebral Hemorrhage by Regulating Neuroinflammation
por: Mengtian Guo, et al.
Publicado: (2023-04-01)

Intranasal Methylprednisolone Ameliorates Neuroinflammation Induced by Chronic Toluene Exposure
por: Manuel F. Giraldo-Velásquez, et al.
Publicado: (2022-06-01)

Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers.
por: Lakhal, S, et al.
Publicado: (2011)

The Role of Exosomes as Mediators of Neuroinflammation in the Pathogenesis and Treatment of Alzheimer’s Disease
por: Shiting Weng, et al.
Publicado: (2022-06-01)

Editorial: The role of exosomes in neuroinflammation and neurodegeneration
por: Yi Wang, et al.
Publicado: (2022-12-01)

Biomedical applications of artificial exosomes for intranasal drug delivery
por: Jinming Zhao, et al.
Publicado: (2023-09-01)

Exosomes for targeted siRNA delivery across biological barriers.
por: Andaloussi, S, et al.
Publicado: (2013)

Exosomes for targeted siRNA delivery across biological barriers
por: Andaloussi, S, et al.
Publicado: (2013)

Intranasal post-cardiac arrest treatment with orexin-A facilitates arousal from coma and ameliorates neuroinflammation.
por: Hiren R Modi, et al.
Publicado: (2017-01-01)

Exosomes as mediators of neuron-glia communication in neuroinflammation
por: María Pascual, et al.
Publicado: (2020-01-01)

Microglial exosomes in retinal neuroinflammation: focus in glaucoma
por: Inês Dinis Aires, et al.
Publicado: (2021-01-01)

Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities
por: Daniel E. Morales, et al.
Publicado: (2022-05-01)

Mir-219 enriched exosomes decrease experimental autoimmune encephalomyelitis symptoms after intranasal administration
por: Osorio-Querejeta, I, et al.
Publicado: (2018)

In vivo evidence for the contribution of peripheral circulating inflammatory exosomes to neuroinflammation
por: Jing Jing Li, et al.
Publicado: (2018-01-01)

Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis
por: Minkyung Kang, et al.
Publicado: (2020-05-01)

Intranasal administration of stem cell-derived exosomes for central nervous system diseases
por: Shuho Gotoh, et al.
Publicado: (2024-01-01)

Low-dose intranasal deferoxamine modulates memory, neuroinflammation, and the neuronal transcriptome in the streptozotocin rodent model of Alzheimer’s disease
por: Jared M. Fine, et al.
Publicado: (2025-01-01)

Delivery of siRNA to the brain by systemic injection of targeted exosomes
por: Alvarez-Erviti, L, et al.
Publicado: (2011)

Oral Microbially Induced Exosomes promote Neuroinflammation and Microglial Cell Senescence
por: Cayla Paradise, et al.
Publicado: (2024-09-01)

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.
por: Alvarez-Erviti, L, et al.
Publicado: (2011)

Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery
por: Van Dommelen, S, et al.
Publicado: (2012)

Intranasal Administration of Mesenchymal Stem Cell-Derived Exosome Alleviates Hypoxic-Ischemic Brain Injury
por: Takuma Ikeda, et al.
Publicado: (2024-03-01)

Exosome-based crosstalk in glaucoma pathogenesis: a focus on oxidative stress and neuroinflammation
por: Lixiang Wang, et al.
Publicado: (2023-07-01)

Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery.
por: van Dommelen, S, et al.
Publicado: (2012)

Intranasal cerium oxide nanoparticles improves locomotor activity and reduces oxidative stress and neuroinflammation in haloperidol-induced parkinsonism in rats
por: Mohammad, et al.
Publicado: (2023-05-01)

An Exosome-Based Therapeutic Strategy Targeting Neuroinflammation in Alzheimer’s Disease with Berberine and Palmatine
por: Zhao X, et al.
Publicado: (2023-08-01)

HIV Neuroinflammation: The Role of Exosomes in Cell Signaling, Prognostic and Diagnostic Biomarkers and Drug Delivery
por: Supriya D. Mahajan, et al.
Publicado: (2021-04-01)

The Treatment of Vasomotor Rhinitis With Intranasal Corticosteroids
por: Eli O. Meltzer, MD
Publicado: (2009-01-01)

Exosome-mediated delivery of siRNA in vitro and in vivo.
por: El-Andaloussi, S, et al.
Publicado: (2012)

Intranasal fentanyl for respiratory distress in children and adolescents with life-limiting conditions
por: Lucas Pieper, et al.
Publicado: (2018-09-01)

The role of intranasal esketamine in treatment-resistant depression
por: A. Fraga, et al.
Publicado: (2021-04-01)

HSV-1 and Cellular miRNAs in CSF-Derived Exosomes as Diagnostically Relevant Biomarkers for Neuroinflammation
por: Christian Scheiber, et al.
Publicado: (2024-07-01)

Intranasal administration of exosomes derived from mesenchymal stem cells ameliorates autistic-like behaviors of BTBR mice
por: Nisim Perets, et al.
Publicado: (2018-11-01)

Intranasal Dexmedetomidine for the Treatment of Pre-operative Anxiety and Insomnia: A Prospective, Randomized, Controlled, and Clinical Trial
por: Wen Zeng, et al.
Publicado: (2022-05-01)

Intranasal Nanoparticles for the Treatment of Depression and Anxiety Disorders
por: Margarida Alberto, et al.
Publicado: (2022-12-01)

Translational Considerations in the Development of Intranasal Treatments for Epilepsy
por: Richard N. Prentice, et al.
Publicado: (2023-01-01)

Intranasal phage treatment overcomes the limitations posed by antibody-mediated neutralization in bacteriophage therapy for Pseudomonas aeruginosa lung infections
por: Dhammika Leshan Wannigama, et al.
Publicado: (2024-12-01)

COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
por: Kuldeep Dhama, et al.
Publicado: (2022-11-01)

Intranasal MMI-0100 Attenuates Aβ1−42- and LPS-Induced Neuroinflammation and Memory Impairments via the MK2 Signaling Pathway
por: JinHong Jiang, et al.
Publicado: (2019-11-01)